Skip to main content
SpringerLink
Log in

Management of Patients with SARS-CoV-2 Infection

  • Chapter
  • First Online:
COVID-19 in Clinical Practice

Part of the book series: In Clinical Practice ((ICP))

  • 605 Accesses

Abstract

COVID-19 is a respiratory disease due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with SARS-CoV-2 infection can experience a range of clinical manifestations, from no symptoms to critical illness. The management and healthcare setting of this disease change according to the degree of its severity. In the mild form, patients need only symptomatic therapy, like antipyretic drugs, while in the more severe form, patients need to be hospitalized, multiparametric monitoring, prevention of complications, anti-inflammatory and antiviral drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

ARDS:

Acute respiratory distress syndrome

COVID-19:

Coronavirus infection disease 2019

CRP:

C-reactive protein

HFNO:

High-flow nasal oxygen

LDH:

Lactate dehydrogenase

SARS-CoV-2:

Severe acute respiratory syndrome coronavirus 2

SpO2:

Saturation of oxygen

References

  1. World Health Organization. Clinical management of COVID-19. Interim Guidance. 2020. WHO/2019-nCoV/clinical/2020.5. https://www.who.int/publications/i/item/clinical-management-of-covid-19.

  2. Greenhalgh T, Koh GCH, Car J. Covid-19: a remote assessment in primary care. BMJ. 2020;368:m1182.

    Article  Google Scholar 

  3. Bianconi V, Violi F, Fallarino F, Pignatelli P, Sahebkar A, Pirro M. Is acetylsalicylic acid a safe and potentially useful choice for adult patients with COVID-19 ? [published online ahead of print, 2020 Jul 23]. Drugs. 2020;80(14):1383–96.

    Article  CAS  Google Scholar 

  4. Ling Y, Xu SB, Lin YX, et al. Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients. Chin Med J. 2020;133(9):1039–43.

    Article  Google Scholar 

  5. RECOVERY Collaborative Group, Horby P, Lim WS, et al. Dexamethasone in hospitalized patients with Covid-19—preliminary report. N Engl J Med. 2021;384(8):693–704. https://doi.org/10.1056/NEJMoa2021436.

    Article  Google Scholar 

  6. Yao X, Ye F, Zhang M, et al. In vitro antiviral activity and projection of optimized dosing Design of Hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 2020;71(15):732–9.

    Article  CAS  Google Scholar 

  7. Skipper CP, Pastick KA, Engen NW, et al. Hydroxychloroquine in nonhospitalized adults with early COVID-19: a randomized trial. Ann Intern Med. 2020:M20–4207.

    Google Scholar 

  8. Llor C, Bjerrum L. Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem. Ther Adv Drug Saf. 2014;5(6):229–41.

    Article  Google Scholar 

  9. Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;324(8):782–93. https://doi.org/10.1001/jama.2020.12839.

    Article  CAS  Google Scholar 

  10. Lam KW, Chow KW, Vo J, et al. Continued in-hospital ACE inhibitor and ARB Use in hypertensive COVID-19 patients is associated with positive clinical outcomes. J Infect Dis. 2020;222(8):1256–64.

    Article  CAS  Google Scholar 

  11. Gianchandani R, Esfandiari NH, Ang L, et al. Managing hyperglycemia in the COVID-19 inflammatory storm. Diabetes. 2020;69(10):2048–53.

    Article  CAS  Google Scholar 

  12. Wang M, Cao R, Zhang L, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30:269–71.

    Article  CAS  Google Scholar 

  13. Beigel JH, Tomashek KM, Dodd LE, et al. Remdesivir for the treatment of Covid-19—preliminary report. N Engl J Med. 2020;383(19):1813–26. https://doi.org/10.1056/NEJMoa2007764.

    Article  CAS  PubMed  Google Scholar 

  14. Goldman JD, Lye DCB, Hui DS, et al. Remdesivir for 5 or 10 days in patients with severe Covid-19. N Engl J Med. 2020;383(19):1827–37.

    Article  CAS  Google Scholar 

  15. Lynch JB, Davitkov P, Anderson DJ, et al. Infectious Diseases Society of America guidelines on infection prevention for health care personnel caring for patients with suspected or known COVID-19. Clin Infect Dis. 2020;ciaa1063.

    Google Scholar 

  16. Tang W, Cao Z, Han M, et al. Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial. BMJ. 2020;369:m1849.

    Article  Google Scholar 

  17. Rosenberg ES, Dufort EM, Udo T, et al. Association of treatment with hydroxychloroquine or azithromycin with in-hospital mortality in patients with COVID-19 in New York state. JAMA. 2020;323(24):2493–502.

    Article  CAS  Google Scholar 

  18. Geleris J, Sun Y, Platt J, et al. Observational study of hydroxychloroquine in hospitalized patients with COVID-19. N Engl J Med. 2020;382(25):2411–8.

    Article  CAS  Google Scholar 

  19. Levi M, Thachil J, Iba T, Levy JH. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020;7(6):e438–40.

    Article  Google Scholar 

  20. Kipshidze N, Dangas G, White CJ, et al. Viral coagulopathy in patients with COVID-19: treatment and care. Clin Appl Thromb Hemost. 2020;26:1076029620936776.

    CAS  PubMed  PubMed Central  Google Scholar 

  21. Rawson TM, Moore LSP, Zhu N, et al. Bacterial and fungal co-infection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis. 2020;ciaa530.

    Google Scholar 

  22. Ranieri VM, Rubenfeld GD, Thompson BT. Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012;307(23):2526–33.

    Google Scholar 

  23. Alhazzani W, Møller MH, Arabi YM, et al. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19). Intensive Care Med. 2020;46(5):854–87.

    Article  Google Scholar 

  24. Sartini C, Tresoldi M, Scarpellini P, et al. Respiratory parameters in patients with COVID-19 after using noninvasive ventilation in the prone position outside the intensive care unit. JAMA. 2020;323(22):2338–40.

    Article  CAS  Google Scholar 

  25. Elharrar X, Trigui Y, Dols AM, et al. Use of prone positioning in nonintubated patients with COVID-19 and hypoxemic acute respiratory failure. JAMA. 2020;323(22):2336–8.

    Article  CAS  Google Scholar 

  26. Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020;180(7):1–11.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Internal Medicine Department, Barone Lombardo Hospital, Canicattì, Italy

    Gabriele A. Vassallo & Giuseppe Augello

  2. Department of Pneumology, Santa Maria Goretti Hospital, Latina, Italy

    Carmela M. Garante

  3. Internal Medicine Department, Paolo Borsellino Hospital, Marsala, Italy

    Anna Cirrincione & Francesco Cristiano Raimondo

  4. Internal Medicine Department, Fatebenefratelli Hospital, Rome, Italy

    Sara Rotunno

  5. Department of Medicine and Therapeutics, University of Ghana Medical School, Accra, Ghana

    Adwoa Agyei-Nkansah

  6. Internal Medicine Unit, Department of Internal Medicine and Gastroenterology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy

    Tommaso Dionisi & Giovanni Addolorato

Authors
  1. Gabriele A. Vassallo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carmela M. Garante
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anna Cirrincione
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sara Rotunno
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Adwoa Agyei-Nkansah
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Francesco Cristiano Raimondo
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Tommaso Dionisi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Giovanni Addolorato
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Giuseppe Augello
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Internal and High Intensity Medicine, Hospital of Circolo Varese, Insubria University, Varese, Italy

    Flavio Tangianu

  2. Department of Internal and Emergency Medicine, Careggi University Hospital, Firenze, Italy

    Ombretta Para

  3. Department of Primary Care, AUSL di Bologna, Bologna, Italy

    Fabio Capello

Rights and permissions

Reprints and permissions

Copyright information

© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Vassallo, G.A. et al. (2021). Management of Patients with SARS-CoV-2 Infection. In: Tangianu, F., Para, O., Capello, F. (eds) COVID-19 in Clinical Practice. In Clinical Practice. Springer, Cham. https://doi.org/10.1007/978-3-030-78021-0_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-78021-0_9

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-78020-3

  • Online ISBN: 978-3-030-78021-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation